These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37516854)

  • 21. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
    Li X; Jiang J; Wu Q; You T; Yang F
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38714850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer.
    Wang H; Yang W; Qin Q; Yang X; Yang Y; Liu H; Lu W; Gu S; Cao X; Feng D; Zhang Z; He J
    Mol Cancer; 2022 Jul; 21(1):151. PubMed ID: 35864508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway.
    Zhu LL; Shi JJ; Guo YD; Yang C; Wang RL; Li SS; Gan DX; Ma PX; Li JQ; Su HC
    Neoplasma; 2023 Apr; 70(2):272-286. PubMed ID: 37226932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
    Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
    Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
    Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
    Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination.
    Chen D; Wu J; Qiu X; Luo S; Huang S; Wei E; Qin M; Huang J; Liu S
    Cancer Gene Ther; 2024 Mar; 31(3):410-419. PubMed ID: 38135696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
    Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
    Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
    Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
    Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
    Ye Q; Cai W; Zheng Y; Evers BM; She QB
    Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trim58 degrades Dynein and regulates terminal erythropoiesis.
    Thom CS; Traxler EA; Khandros E; Nickas JM; Zhou OY; Lazarus JE; Silva AP; Prabhu D; Yao Y; Aribeana C; Fuchs SY; Mackay JP; Holzbaur EL; Weiss MJ
    Dev Cell; 2014 Sep; 30(6):688-700. PubMed ID: 25241935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
    Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.